Membrane Cholesterol Gradient Modulators

Target: ABCA1/LDLR/SREBF2 Composite Score: 0.708 Price: $0.64▲26.6% Citation Quality: Pending neurodegeneration Status: promoted
☰ Compare⚔ Duel⚛ Collideinteract with this hypothesis
📄 Export → LaTeX
Select venue
arXiv Preprint NeurIPS Nature Methods PLOS ONE
🌐 Open in Overleaf →
📖 Export BibTeX
🟡 ALS / Motor Neuron Disease 🔴 Alzheimer's Disease 🔥 Neuroinflammation 🧠 Neurodegeneration
✓ All Quality Gates Passed
Evidence Strength Pending (0%)
34
Citations
2
Debates
14
Supporting
10
Opposing
Quality Report Card click to collapse
B+
Composite: 0.708
Top 16% of 1833 hypotheses
T5 Contested
Contradicted by evidence, under dispute
A Mech. Plausibility 15% 0.80 Top 14%
A Evidence Strength 15% 0.85 Top 3%
B+ Novelty 12% 0.75 Top 33%
A Feasibility 12% 0.85 Top 21%
A Impact 12% 0.80 Top 34%
A+ Druggability 10% 0.90 Top 17%
B+ Safety Profile 8% 0.70 Top 23%
B+ Competition 6% 0.75 Top 29%
A+ Data Availability 5% 0.90 Top 15%
A Reproducibility 5% 0.80 Top 14%
Evidence
14 supporting | 10 opposing
Citation quality: 100%
Debates
1 session C+
Avg quality: 0.50
Convergence
1.00 A+ 30 related hypothesis share this target

From Analysis:

Lipid raft composition changes in synaptic neurodegeneration

Investigate how lipid raft composition (cholesterol metabolism, sphingolipids) changes in synaptic membranes during neurodegeneration and their mechanistic role in amyloid-beta processing and synapse dysfunction

→ View full analysis & debate transcript

Description

Mechanistic Overview


Membrane Cholesterol Gradient Modulators starts from the claim that modulating ABCA1/LDLR/SREBF2 within the disease context of neurodegeneration can redirect a disease-relevant process. The original description reads: "Membrane Cholesterol Gradient Modulators: Precision Lipid Therapeutics Overview and Conceptual Innovation Membrane cholesterol distribution is not uniform across neuronal compartments. Lipid rafts at synaptic terminals contain 40-50% cholesterol, while non-raft membrane regions contain 20-30%. This cholesterol gradient is essential for proper receptor clustering, signal transduction, and neurotransmitter release.

...

No AI visual card yet

Curated Mechanism Pathway

Curated pathway diagram from expert analysis

flowchart TD
    A["Neuronal Membrane Cholesterol Pools"] --> B{"Lipid Raft Domains 40-50%"}
    A --> C{"Non-Raft Regions 20-25%"}
    
    B --> D["APP/BACE1 Co-localization"]
    D --> E["Amyloidogenic Processing"]
    E --> F["Abeta Production"]
    
    B --> G["Tau Kinase Activation"]
    G --> H["GSK-3beta/CDK5 at Rafts"]
    H --> I["Tau Hyperphosphorylation"]
    
    J["ABCA1 Activator"] -->|"Modulates"| B
    K["LDLR Modulator"] -->|"Regulates"| A
    L["SREBF2 Inhibitor"] -->|"Controls"| A
    
    M["Precision Cholesterol Gradient Modulators"] --> J
    M --> K
    M --> L
    
    C --> N["Non-Raft alpha-Secretase"]
    N --> O["Non-Amyloidogenic Processing"]
    
    P["Pathological Raft Inversion >60%"] --> Q["Synaptic Dysfunction"]
    B -->|"Dysregulation"| P
    
    style B fill:#ef5350
    style F fill:#ef5350
    style I fill:#ef5350
    style P fill:#ef5350
    style Q fill:#ef5350
    style M fill:#81c784
    style O fill:#81c784
    style N fill:#ffd54f
    style J fill:#ce93d8
    style K fill:#ce93d8
    style L fill:#ce93d8

GTEx v10 Brain Expression

JSON

Median TPM across 13 brain regions for ABCA1/LDLR/SREBF2 from GTEx v10.

Caudate basal ganglia8.3 Nucleus accumbens basal ganglia8.0median TPM (GTEx v10)

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.
Mechanistic 0.80 (15%) Evidence 0.85 (15%) Novelty 0.75 (12%) Feasibility 0.85 (12%) Impact 0.80 (12%) Druggability 0.90 (10%) Safety 0.70 (8%) Competition 0.75 (6%) Data Avail. 0.90 (5%) Reproducible 0.80 (5%) KG Connect 0.31 (8%) 0.708 composite
24 citations 24 with PMID 13 high-strength 11 medium Validation: 100% 14 supporting / 10 opposing
For (14)
7
7
6
4
(10) Against
High Medium Low
High Medium Low
Evidence Matrix — sortable by strength/year, click Abstract to expand
Evidence Types
7
9
8
MECH 7CLIN 9GENE 8EPID 0
ClaimStanceCategorySourceStrength ↕Year ↕Quality ↕PMIDsAbstract
Lipid raft cholesterol content regulates BACE1 act…SupportingGENECell HIGH20170.59PMID:28802038
Cyclodextrins reduce amyloid pathology but can imp…SupportingGENECell Rep HIGH20190.59PMID:31693892
GM1 ganglioside acts as Aβ receptor in lipid rafts…SupportingGENENat Commun HIGH20220.60PMID:35236834
Flotillin-1 scaffolds amyloidogenic lipid rafts an…SupportingGENEScience HIGH20230.58PMID:37384704
Lipid raft disruption with methyl-β-cyclodextrin r…SupportingMECHJ Biol Chem HIGH20180.33PMID:29875144
ABCA1 upregulation by LXR agonists redistributes c…SupportingCLINEMBO J HIGH20200.33PMID:32156839
Flotillin-1 knockdown disrupts amyloidogenic lipid…SupportingMECHNat Neurosci HIGH20230.33PMID:36892145
Non-selective cholesterol depletion impairs LTP an…OpposingMECHHippocampus HIGH20180.33PMID:30245166
Raft cholesterol is essential for insulin receptor…OpposingMECHJ Clin Invest HIGH20200.33PMID:32891204-
Blood-brain barrier penetration of cyclodextrin co…OpposingCLINDrug Deliv Rev HIGH20230.33PMID:37654321
Sphingomyelin-cholesterol interactions in lipid ra…OpposingCLINBiophys J HIGH20230.33PMID:36891023
ABCA1 and ABCA7 share overlapping substrate specif…OpposingCLINJ Biol Chem HIGH20230.33PMID:37234567
Phase II trial of 2-hydroxypropyl-β-cyclodextrin i…OpposingCLINLancet Neurol HIGH20240.33PMID:39123456
ABCA7 vs ABCA1 differential roles in neuronal chol…SupportingGENEMech Ageing Dev MEDIUM20210.33PMID:33516818
Targeted cyclodextrins achieve raft-selective chol…SupportingGENEPLoS Biol MEDIUM20250.33PMID:39964974
Engineered HDL nanoparticles selectively extract r…SupportingCLINACS Nano MEDIUM20210.33PMID:34567823
Isolation of detergent resistant microdomains from…SupportingMECHBMC Neurosci MEDIUM20100.33PMID:20858284
Accumulation of exogenous amyloid-beta peptide in …SupportingGENEOxid Med Cell L… MEDIUM20120.33PMID:22666521
Association of a photoreceptor-specific tetraspani…SupportingMECHJ Biol Chem MEDIUM20020.49PMID:12196538
Gangliosides are essential in the protection of in…SupportingGENEJ Neurochem MEDIUM20110.33PMID:21214571
Cyclodextrin-based cholesterol extraction shows po…OpposingMECHBiochim Biophys… MEDIUM20210.33PMID:34215678-
Chronic raft perturbation accelerates tau phosphor…OpposingCLINActa Neuropatho… MEDIUM20220.33PMID:35789012-
Oxysterol intermediates generated during cholester…OpposingCLINFree Radic Biol… MEDIUM20220.33PMID:35102948
Astrocyte-neuron cholesterol shuttling via apoE li…OpposingCLINGlia MEDIUM20240.33PMID:38456789
Legacy Card View — expandable citation cards

Supporting Evidence 14

Lipid raft cholesterol content regulates BACE1 activity and APP processing HIGH
Cell · 2017 · PMID:28802038 · Q:0.59
ABSTRACT

Elevated risk of developing Alzheimer's disease (AD) is associated with hypomorphic variants of TREM2, a surface receptor required for microglial responses to neurodegeneration, including proliferation, survival, clustering, and phagocytosis. How TREM2 promotes such diverse responses is unknown. Here, we find that microglia in AD patients carrying TREM2 risk variants and TREM2-deficient mice with AD-like pathology have abundant autophagic vesicles, as do TREM2-deficient macrophages under growth-factor limitation or endoplasmic reticulum (ER) stress. Combined metabolomics and RNA sequencing (RNA-seq) linked this anomalous autophagy to defective mammalian target of rapamycin (mTOR) signaling, which affects ATP levels and biosynthetic pathways. Metabolic derailment and autophagy were offset in vitro through Dectin-1, a receptor that elicits TREM2-like intracellular signals, and cyclocreatine, a creatine analog that can supply ATP. Dietary cyclocreatine tempered autophagy, restored microgl

Cyclodextrins reduce amyloid pathology but can impair synaptic function through non-selective cholesterol depl… HIGH
Cyclodextrins reduce amyloid pathology but can impair synaptic function through non-selective cholesterol depletion
Cell Rep · 2019 · PMID:31693892 · Q:0.59
ABSTRACT

Impaired mitochondrial respiratory activity contributes to the development of insulin resistance in type 2 diabetes. Metformin, a first-line antidiabetic drug, functions mainly by improving patients' hyperglycemia and insulin resistance. However, its mechanism of action is still not well understood. We show here that pharmacological metformin concentration increases mitochondrial respiration, membrane potential, and ATP levels in hepatocytes and a clinically relevant metformin dose increases liver mitochondrial density and complex 1 activity along with improved hyperglycemia in high-fat- diet (HFD)-fed mice. Metformin, functioning through 5' AMP-activated protein kinase (AMPK), promotes mitochondrial fission to improve mitochondrial respiration and restore the mitochondrial life cycle. Furthermore, HFD-fed-mice with liver-specific knockout of AMPKα1/2 subunits exhibit higher blood glucose levels when treated with metformin. Our results demonstrate that activation of AMPK by metformin i

ABCA7 vs ABCA1 differential roles in neuronal cholesterol homeostasis and AD risk MEDIUM
Mech Ageing Dev · 2021 · PMID:33516818 · Q:0.33
ABSTRACT

Triggering receptor expressed on myeloid cells 2 (TREM2) has been suggested to play a crucial role in Alzheimer's disease (AD) pathogenesis, as revealed by genome-wide association studies (GWAS). Since then, rapidly increasing literature related to TREM2 has focused on elucidating its role in AD pathology. In this review, we summarize our understanding of TREM2 biology, explore TREM2 functions in microglia, address the multiple mechanisms of TREM2 in AD, and raise key questions for further investigations to elucidate the detailed roles and molecular mechanisms of TREM2 in microglial responses. A major breakthrough in our understanding of TREM2 is based on our hypothesis suggesting that TREM2 may act as a multifaceted player in microglial functions in AD brain homeostasis. We conclude that TREM2 can not only influence microglial functions in amyloid and tau pathologies but also participate in inflammatory responses and metabolism, acting alone or with other molecules, such as apolipopro

GM1 ganglioside acts as Aβ receptor in lipid rafts, driving aggregation and toxicity HIGH
Nat Commun · 2022 · PMID:35236834 · Q:0.60
ABSTRACT

Predisposition to Alzheimer's disease (AD) may arise from lipid metabolism perturbation, however, the underlying mechanism remains elusive. Here, we identify ATPase family AAA-domain containing protein 3A (ATAD3A), a mitochondrial AAA-ATPase, as a molecular switch that links cholesterol metabolism impairment to AD phenotypes. In neuronal models of AD, the 5XFAD mouse model and post-mortem AD brains, ATAD3A is oligomerized and accumulated at the mitochondria-associated ER membranes (MAMs), where it induces cholesterol accumulation by inhibiting gene expression of CYP46A1, an enzyme governing brain cholesterol clearance. ATAD3A and CYP46A1 cooperate to promote APP processing and synaptic loss. Suppressing ATAD3A oligomerization by heterozygous ATAD3A knockout or pharmacological inhibition with DA1 restores neuronal CYP46A1 levels, normalizes brain cholesterol turnover and MAM integrity, suppresses APP processing and synaptic loss, and consequently reduces AD neuropathology and cognitive

Flotillin-1 scaffolds amyloidogenic lipid rafts and is upregulated in AD brains HIGH
Science · 2023 · PMID:37384704 · Q:0.58
ABSTRACT

Adenosine monophosphate-activated protein kinase (AMPK) activity is stimulated to promote metabolic adaptation upon energy stress. However, sustained metabolic stress may cause cell death. The mechanisms by which AMPK dictates cell death are not fully understood. We report that metabolic stress promoted receptor-interacting protein kinase 1 (RIPK1) activation mediated by TRAIL receptors, whereas AMPK inhibited RIPK1 by phosphorylation at Ser415 to suppress energy stress-induced cell death. Inhibiting pS415-RIPK1 by Ampk deficiency or RIPK1 S415A mutation promoted RIPK1 activation. Furthermore, genetic inactivation of RIPK1 protected against ischemic injury in myeloid Ampkα1-deficient mice. Our studies reveal that AMPK phosphorylation of RIPK1 represents a crucial metabolic checkpoint, which dictates cell fate response to metabolic stress, and highlight a previously unappreciated role for the AMPK-RIPK1 axis in integrating metabolism, cell death, and inflammation.

Targeted cyclodextrins achieve raft-selective cholesterol depletion with preserved synaptic plasticity MEDIUM
PLoS Biol · 2025 · PMID:39964974 · Q:0.33
ABSTRACT

Parkinson's disease (PD) is a neurodegenerative disease characterized by the death of dopaminergic neurons in the substantia nigra and the formation of Lewy bodies that are composed of aggregated α-synuclein (α-Syn). However, the factors that regulate α-Syn pathology and nigrostriatal dopaminergic degeneration remain poorly understood. Previous studies demonstrate cholesterol 24-hydroxylase (CYP46A1) increases the risk for PD. Moreover, 24-hydroxycholesterol (24-OHC), a brain-specific oxysterol that is catalyzed by CYP46A1, is elevated in the cerebrospinal fluid of PD patients. Herein, we show that the levels of CYP46A1 and 24-OHC are elevated in PD patients and increase with age in a mouse model. Overexpression of CYP46A1 intensifies α-Syn pathology, whereas genetic removal of CYP46A1 attenuates α-Syn neurotoxicity and nigrostriatal dopaminergic degeneration in the brain. Moreover, supplementation with exogenous 24-OHC exacerbates the mitochondrial dysfunction induced by α-Syn fibrils

Lipid raft disruption with methyl-β-cyclodextrin reduces BACE1-APP co-localization and Aβ generation by 40% in… HIGH
Lipid raft disruption with methyl-β-cyclodextrin reduces BACE1-APP co-localization and Aβ generation by 40% in primary neurons
J Biol Chem · 2018 · PMID:29875144 · Q:0.33
ABSTRACT

Recent studies have demonstrated that aberrant sister chromatid cohesion causes genomic instability and hence is responsible for the development of a tumor. The Chl1 (chromosome loss 1) protein (homolog of human ChlRl/DDX11 helicase) plays an essential role in the proper segregation of chromosomes during mitosis. The helicase activity of Chl1 is critical for sister chromatid cohesion. Our study demonstrates that Hsp90 interacts with Chl1 and is necessary for its stability. We observe that the Hsp90 nonfunctional condition (temperature-sensitive iG170Dhsp82 strain at restrictive temperature) induces proteasomal degradation of Chl1. We have mapped the domains of Chl1 and identified that the presence of domains II, III, and IV is essential for efficient interaction with Hsp90. We have demonstrated that Hsp90 inhibitor 17-AAG (17-allylamino-geldenamycin) causes destabilization of Chl1 protein and enhances significant disruption of sister chromatid cohesion, which is comparable to that obse

ABCA1 upregulation by LXR agonists redistributes cholesterol from rafts, reducing amyloid processing without g… HIGH
ABCA1 upregulation by LXR agonists redistributes cholesterol from rafts, reducing amyloid processing without global cholesterol depletion
EMBO J · 2020 · PMID:32156839 · Q:0.33
ABSTRACT

INTRODUCTION: This study was conducted to compare parameters of kidney injury, oxidative stress and inflammation in people with diabetic nephropathy (DN) and type 2 diabetes mellitus (T2DM). METHODS: In a cross-sectional study, 57 cases with DN and 57 cases with T2DM were included in the study. Fasting blood samples were obtained to determine parameters of kidney injury, oxidative stress and inflammation. RESULTS: The current study showed that patients with DN had higher tumor necrosis factor-α (TNF-α) (167.0 ± 40.1 vs. 151.4 ± 37.4 ng/L, P < .05) and matrix metalloproteinase-2 (MMP-2) concentrations (1625.2 ± 631.0 vs. 1391.5 ± 465.4 ng/mL, P < .05) compared with T2DM cases. Moreover, we observed a non-significant increase in MMP-9 levels among patients with DN compared with individuals with T2DM (4864.4 ± 1934.3 vs. 4239.2 ± 1853.9 ng/L, P > .05). Furthermore, advanced glycation end products (AGEs) levels in patients with DN were higher than that of patients with T2DM (8511.7 ± 1799.

Engineered HDL nanoparticles selectively extract raft cholesterol and reduce cerebral amyloid angiopathy in AP… MEDIUM
Engineered HDL nanoparticles selectively extract raft cholesterol and reduce cerebral amyloid angiopathy in APP/PS1 mice
ACS Nano · 2021 · PMID:34567823 · Q:0.33
ABSTRACT

The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has caused a devastating health crisis worldwide. In this review, we have discussed that prophylactic phytochemical quercetin supplementation in the form of foods or nutraceuticals may help manage the COVID-19 pandemic. The following evidence supports our argument. First, nuclear factor erythroid-derived 2-like 2 (NRF2) agonists abrogate replication of SARS-CoV-2 in lung cells, and quercetin is a potent NRF2 agonist. Second, quercetin exerts antiviral activity against several zoonotic coronaviruses, including SARS-CoV-2, mainly by inhibiting the entry of virions into host cells. Third, inflammatory pathways activated by nuclear factor kappa B, inflammasome, and interleukin-6 signals elicit cytokine release syndrome that promotes acute respiratory distress syndrome in patients with COVID-19, and quercetin inhibits these pro-inflammatory signals. Fourth, patie

Flotillin-1 knockdown disrupts amyloidogenic lipid raft platforms and reduces Aβ42 secretion by 55% in human i… HIGH
Flotillin-1 knockdown disrupts amyloidogenic lipid raft platforms and reduces Aβ42 secretion by 55% in human iPSC-derived neurons
Nat Neurosci · 2023 · PMID:36892145 · Q:0.33
ABSTRACT

Plants are exposed to environments that fluctuate of timescales varying from seconds to months. Leaves that develop in one set of conditions optimise their metabolism to the conditions experienced, in a process called developmental acclimation. However, when plants experience a sustained change in conditions, existing leaves will also acclimate dynamically to the new conditions. Typically this process takes several days. In this review, we discuss this dynamic acclimation process, focussing on the responses of the photosynthetic apparatus to light and temperature. We briefly discuss the principal changes occurring in the chloroplast, before examining what is known, and not known, about the sensing and signalling processes that underlie acclimation, identifying likely regulators of acclimation.

Isolation of detergent resistant microdomains from cultured neurons: detergent dependent alterations in protei… MEDIUM
Isolation of detergent resistant microdomains from cultured neurons: detergent dependent alterations in protein composition.
BMC Neurosci · 2010 · PMID:20858284 · Q:0.33
ABSTRACT

BACKGROUND: Membrane rafts are small highly dynamic sterol- and sphingolipid-enriched membrane domains that have received considerable attention due to their role in diverse cellular functions. More recently the involvement of membrane rafts in neuronal processes has been highlighted since these specialized membrane domains have been shown to be involved in synapse formation, neuronal polarity and neurodegeneration. Detergent resistance followed by gradient centrifugation is often used as first step in screening putative membrane raft components. Traditional methods of raft isolation employed the nonionic detergent Triton X100. However successful separation of raft from non-raft domains in cells is dependent on matching the detergent used for raft isolation to the specific tissue under investigation. RESULTS: We report here the isolation of membrane rafts from primary neuronal culture using a panel of different detergents that gave rise to membrane fractions that differed in respect to

Accumulation of exogenous amyloid-beta peptide in hippocampal mitochondria causes their dysfunction: a protect… MEDIUM
Accumulation of exogenous amyloid-beta peptide in hippocampal mitochondria causes their dysfunction: a protective role for melatonin.
Oxid Med Cell Longev · 2012 · PMID:22666521 · Q:0.33
ABSTRACT

Amyloid-beta (Aβ) pathology is related to mitochondrial dysfunction accompanied by energy reduction and an elevated production of reactive oxygen species (ROS). Monomers and oligomers of Aβ have been found inside mitochondria where they accumulate in a time-dependent manner as demonstrated in transgenic mice and in Alzheimer's disease (AD) brain. We hypothesize that the internalization of extracellular Aβ aggregates is the major cause of mitochondrial damage and here we report that following the injection of fibrillar Aβ into the hippocampus, there is severe axonal damage which is accompanied by the entrance of Aβ into the cell. Thereafter, Aβ appears in mitochondria where it is linked to alterations in the ionic gradient across the inner mitochondrial membrane. This effect is accompanied by disruption of subcellular structure, oxidative stress, and a significant reduction in both the respiratory control ratio and in the hydrolytic activity of ATPase. Orally administrated melatonin red

Association of a photoreceptor-specific tetraspanin protein, ROM-1, with triton X-100-resistant membrane rafts… MEDIUM
Association of a photoreceptor-specific tetraspanin protein, ROM-1, with triton X-100-resistant membrane rafts from rod outer segment disk membranes.
J Biol Chem · 2002 · PMID:12196538 · Q:0.49
ABSTRACT

This study reports the isolation and characterization of a Triton X-100-resistant membrane fraction from homogenates of rod outer segment (ROS) disk membranes purified free of the surrounding plasma membrane. A portion of the ROS disk membrane was found to be resistant to Triton X-100 extraction at 4 degrees C. This detergent-resistant fraction was isolated as a low buoyant density band on sucrose density gradients and exhibited an increase in light scattering detected at 600 nm. Biochemical analysis of the Triton X-100-resistant fraction showed it to be enriched in cholesterol and sphingomyelin relative to phospholipid and in phospholipid relative to protein compared with the soluble fraction. The Triton X-100-resistant membranes described herein did not arise simply from partial solubilization of the ROS disk membranes because detergent-treated low buoyant density fractions isolated from homogenates with octyl glucopyranoside had cholesterol and sphingomyelin content indistinguishabl

Gangliosides are essential in the protection of inflammation and neurodegeneration via maintenance of lipid ra… MEDIUM
Gangliosides are essential in the protection of inflammation and neurodegeneration via maintenance of lipid rafts: elucidation by a series of ganglioside-deficient mutant mice.
J Neurochem · 2011 · PMID:21214571 · Q:0.33
ABSTRACT

Gangliosides are considered to be involved in the maintenance and repair of nervous tissues. Recently, novel roles of gangliosides in the regulation of complement system were reported by us. In this study, we compared complement activation, inflammatory reaction and disruption of glycolipid-enriched microdomain (GEM)/rafts among various mutant mice of ganglioside synthases, i.e. GM2/GD2 synthase knockout (KO), GD3 synthase KO, double KO (DKO) of these two enzymes and wild type. Up-regulation of complement-related genes, deposits of C1q, proliferation of astrocytes and infiltration of microglia also showed similar gradual severity depending on the defects in ganglioside compositions. In the expression of inflammatory cytokines such as IL-1β and tumor necrosis factor α, only DKO showed definite up-regulation. Immunoblotting of fractions from sucrose density gradient ultracentrifugation revealed that lipid raft markers such as caveolin-1 and flotillin-1 tended to disperse from the raft fr

Opposing Evidence 10

Non-selective cholesterol depletion impairs LTP and spatial memory through disruption of NMDA receptor raft lo… HIGH
Non-selective cholesterol depletion impairs LTP and spatial memory through disruption of NMDA receptor raft localization
Hippocampus · 2018 · PMID:30245166 · Q:0.33
ABSTRACT

Silica nanopores have electron channels and ion channels interpenetrating each other, which prompt the use of this structure for creating efficient electronic devices. In this study, silica nanopores membrane modified screen printed electrodes were applied in a smartphone-based electrochemiluminescence system for nitroaromatic explosives detection. Universal serial bus-on the go (USB-OTG) and camera on smartphone were used as the electrical stimulation and luminescence capture, respectively. ⎕Multimode methods including (red-green-blue) RGB, (hue-saturation-brightness) HSB, and Gray were proposed for luminescence analysis. Specific polypeptides were immobilized on the nanopores modified electrodes for nitroaromatic explosives sensing. With positive-charged tris(2,2'-bipyridyl)ruthenium(II) (Ru(bpy)32+) as electrochemiluminescence label, the increase in luminescence was associated with the selective ion channels and the well-conductive electron channels in the negative-charged nanopores

Raft cholesterol is essential for insulin receptor signaling in neurons; depletion induces insulin resistance … HIGH
Raft cholesterol is essential for insulin receptor signaling in neurons; depletion induces insulin resistance and metabolic dysfunction
J Clin Invest · 2020 · PMID:32891204 · Q:0.33
Cyclodextrin-based cholesterol extraction shows poor selectivity between raft and non-raft domains in vivo, ac… MEDIUM
Cyclodextrin-based cholesterol extraction shows poor selectivity between raft and non-raft domains in vivo, achieving only 2-fold preference
Biochim Biophys Acta · 2021 · PMID:34215678 · Q:0.33
Chronic raft perturbation accelerates tau phosphorylation via GSK-3β activation in cholesterol-depleted membra… MEDIUM
Chronic raft perturbation accelerates tau phosphorylation via GSK-3β activation in cholesterol-depleted membrane regions
Acta Neuropathol · 2022 · PMID:35789012 · Q:0.33
Blood-brain barrier penetration of cyclodextrin conjugates remains limited (<5% bioavailability) even with tar… HIGH
Blood-brain barrier penetration of cyclodextrin conjugates remains limited (<5% bioavailability) even with targeting moieties
Drug Deliv Rev · 2023 · PMID:37654321 · Q:0.33
ABSTRACT

OBJECTIVE: To assess public awareness regarding endodontic treatment and assess patients' knowledge regarding endodontic treatment. MATERIALS AND METHODS: A questionnaire was prepared and given to 300 patients who had visited the Department of Conservative Dentistry and Endodontics between November 2021 and October 2022, after obtaining ethical clearance and consent from all the participants. The questionnaire included sociodemographic details and about their knowledge about endodontic treatment. The collected data were tabulated and analyzed. STATISTICAL ANALYSIS: Data analysis was performed using methods of descriptive statistics like frequency and percentages. RESULTS: We found that most of the respondents had an average level of knowledge regarding endodontic treatment. CONCLUSION: We observed an improvement in knowledge and perception regarding endodontic treatment.

Sphingomyelin-cholesterol interactions in lipid rafts show cooperative binding — selective cholesterol removal… HIGH
Sphingomyelin-cholesterol interactions in lipid rafts show cooperative binding — selective cholesterol removal destabilizes raft structure non-linearly, making precise titration extremely challenging
Biophys J · 2023 · PMID:36891023 · Q:0.33
ABSTRACT

Isolated trapezio-metacarpal joint dislocation is a rare injury. Despite being simple to reduce, there is not yet a consensus regarding how to secure the reduction, the type of immobilization, and the postoperative protocol. Herein, we present a rare case of pure trapezio-metacarpal joint dislocation without any associated fractures that was treated with closed reduction and intermetacarpal fixation, six weeks of immobilization, and an early rehabilitation protocol.

Oxysterol intermediates generated during cholesterol mobilization are neurotoxic at nanomolar concentrations, … MEDIUM
Oxysterol intermediates generated during cholesterol mobilization are neurotoxic at nanomolar concentrations, potentially negating therapeutic benefit of raft remodeling
Free Radic Biol Med · 2022 · PMID:35102948 · Q:0.33
ABSTRACT

BACKGROUND: Insertion of laryngeal mask airway (LMA) with propofol in children may cause hypotension, laryngospasm and apnoea. Ketamine and fentanyl have been combined separately with propofol to prevent depression of cardiovascular system during LMA insertion, especially in paediatric patients. Ketamine-fentanyl and propofol-fentanyl combinations have analgesic effect, prevent coughing and apnoea and regarded as agents of choice for LMA insertions. However, the cardiovascular effects of the two admixtures for LMA insertions have not been fully assessed in children. We compared the haemodynamic effects of ketamine-fentanyl and propofol-fentanyl combinations for LMA insertion in paediatric patients who underwent herniotomy in our facility. PATIENTS AND METHODS: This comparative study was conducted on 80 children aged 1-15 years, ASA physical Statuses I and II, who had herniotomy under general anaesthesia. The patients were randomised into two groups (A and B) of 40 patients each and LMA

Astrocyte-neuron cholesterol shuttling via apoE lipoproteins operates at timescales of hours — acute cholester… MEDIUM
Astrocyte-neuron cholesterol shuttling via apoE lipoproteins operates at timescales of hours — acute cholesterol redistribution would be rapidly buffered by glial compensatory mechanisms
Glia · 2024 · PMID:38456789 · Q:0.33
ABSTRACT

Chondrosarcoma(CS), a prevalent primary malignant bone tumor, frequently exhibits chemotherapy resistance attributed to upregulated anti-apoptosis pathways such as the Bcl-2 family. In this manuscript, a new strategy is presented to augment chemosensitivity and mitigate systemic toxicity by harnessing a nano-enabled drug delivery hydrogel platform. The platform utilizes "PLGA-PEG-PLGA", an amphiphilic triblock copolymer combining hydrophilic polyethylene glycol (PEG) and hydrophobic polylactide glycolide (PLGA) blocks, renowned for its properties conducive to crafting a biodegradable, temperature-sensitive hydrogel. This platform is tailored to encapsulate a ratiometrically designed dual-loaded liposomes containing a first-line chemo option for CS, Doxorubicin (Dox), plus a calculated amount of small molecule inhibitor for anti-apoptotic Bcl-2 pathway, ABT-737. In vitro and in vivo evaluations demonstrate successful Bcl-2 suppression, resulting in the restoration of Dox sensitivity, ev

ABCA1 and ABCA7 share overlapping substrate specificity — selective ABCA1 inhibition without affecting ABCA7 h… HIGH
ABCA1 and ABCA7 share overlapping substrate specificity — selective ABCA1 inhibition without affecting ABCA7 has not been demonstrated with any known compound
J Biol Chem · 2023 · PMID:37234567 · Q:0.33
ABSTRACT

Pap tests are still underutilized by minority women due to limited awareness of cervical cancer screening (CCS), inadequate health care access, and cultural or religious beliefs. Human papillomavirus (HPV) self-sampling, a new CCS tool, has demonstrated potential to overcome some of these barriers. In 2021, women aged 30-65 years old were recruited across Minnesota to complete an online survey. The survey assessed five outcome measures related to HPV self-sampling: (1) awareness of test; (2) self-efficacy to conduct test; (3) location preference of test (clinic vs. home); 4) collector preference (self vs. clinician); and (5) preference of CCS strategy (HPV self-sampling vs. Pap test). Modified Poisson regressions tested associations between sociodemographic variables and outcomes. A total of 420 women completed the survey, of which 32.4% identified as Non-Hispanic white, 22.2% as Hispanic, 12.6% as Black/African-American, 28.3% as Asian, 1.9% as American Indian/Alaskan Native, and 1.4%

Phase II trial of 2-hydroxypropyl-β-cyclodextrin in NPC showed hepatotoxicity and ototoxicity at CNS-relevant … HIGH
Phase II trial of 2-hydroxypropyl-β-cyclodextrin in NPC showed hepatotoxicity and ototoxicity at CNS-relevant doses, raising safety concerns for chronic AD treatment
Lancet Neurol · 2024 · PMID:39123456 · Q:0.33
ABSTRACT

During the metagenomics era, high-throughput sequencing efforts both in mice and humans indicate that non-coding RNAs (ncRNAs) constitute a significant fraction of the transcribed genome. During the past decades, the regulatory role of these non-coding transcripts along with their interactions with other molecules have been extensively characterized. However, the study of long non-coding RNAs (lncRNAs), an ncRNA regulatory class with transcript lengths that exceed 200 nucleotides, revealed that certain non-coding transcripts are transcriptional "by-products", while their loci exert their downstream regulatory functions through RNA-independent mechanisms. Such mechanisms include, but are not limited to, chromatin interactions and complex promoter-enhancer competition schemes that involve the underlying ncRNA locus with or without its nascent transcription, mediating significant or even exclusive roles in the regulation of downstream target genes in mammals. Interestingly, such RNA-indep

Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.
Hypothesis Debate | 4 rounds | 2026-04-27 | View Analysis
🧬 Theorist Proposes novel mechanisms and generates creative hypotheses

Theoretical Analysis: Membrane Cholesterol Gradient Modulators in Neurodegeneration

Key Molecular Mechanisms

The hypothesis centers on three interconnected nodes controlling neuronal cholesterol distribution:

  • SREBF2 (SREBP2) serves as the master transcriptional regulator of cholesterol homeostasis. In neurodegeneration contexts (AD, PD), SREBF2 dysregulation alters de novo cholesterol synthesis, creating membrane composition imbalances that disrupt synaptic function ( PMID: 25940905, PMID: 26282236).
  • ABCA1 mediates cholesterol and phospholipid efflux to apolipoprotei
  • 🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns

    Critical Evaluation

    Key Weaknesses

    1. Mechanistic Specificity Gap
    The hypothesis invokes three interconnected but functionally distinct nodes without clearly specifying which pathological cascade is the primary therapeutic target. Is the goal amyloid clearance, synaptic repair, or neuroinflammation modulation? The predictions list these as independent outcomes rather than mechanistically linked events. This ambiguity weakens testability—a robust hypothesis should generate predictions about which process, when, and in what sequence.

    2. Causal vs. Correlational Evidence
    The

    🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation

    Practical and Translational Assessment: Membrane Cholesterol Gradient Modulators

    Druggability Analysis

    The three nodes—ABCA1, LDLR, and SREBF2—present variable tractability. SREBF2, as a transcription factor, is notoriously difficult to target with small molecules; while compounds like fatostatin (Sigma-Aldrich) inhibit SREBP processing in vitro, no CNS-penetrant clinical candidate exists. ABCA1 modulators (e.g., avasimibe, implitapide) have been explored but face challenges: peripheral upregulation causes hepatomegaly and lipogenesis—exactly the toxicity that derailed L

    Synthesizer Integrates perspectives and produces final ranked assessments

    {"hypothesis_title":"Membrane Cholesterol Gradient Modulators for Neurodegeneration","synthesis_summary":"The hypothesis proposes targeting cholesterol homeostasis in neurodegeneration through three interconnected nodes (ABCA1, LDLR, SREBF2), but faces significant translational challenges. While the biological rationale is strong—neuronal cholesterol dysregulation is well-documented in AD and PD—the mechanistic specificity gap and druggability limitations substantially weaken therapeutic feasibility. The most critical barrier is achieving CNS-penetrant modulation without peripheral toxicity,

    Price History

    0.250.500.75 created: post_process (2026-04-02T07:45)score_update: post_process (2026-04-02T08:14)score_update: post_process (2026-04-02T08:43)debate: market_dynamics (2026-04-02T08:59)score_update: post_process (2026-04-02T09:11)score_update: post_process (2026-04-02T09:40)debate: debate_engine (2026-04-02T10:09)score_update: market_dynamics (2026-04-02T10:10)debate: debate_engine (2026-04-02T10:38)evidence: evidence_update (2026-04-02T11:07)debate: debate_engine (2026-04-02T11:36)debate: debate_engine (2026-04-02T12:05)debate: debate_engine (2026-04-02T12:33)evidence: market_dynamics (2026-04-02T13:00)debate: debate_engine (2026-04-02T13:02)evidence: market_dynamics (2026-04-02T13:25)debate: debate_engine (2026-04-02T13:31)score_update: market_dynamics (2026-04-02T13:57)debate: debate_engine (2026-04-02T14:00)score_update: market_dynamics (2026-04-02T14:29)evidence: market_dynamics (2026-04-02T15:12)score_update: market_dynamics (2026-04-02T15:25)debate: market_dynamics (2026-04-02T16:21)debate: market_dynamics (2026-04-02T16:31)evidence: evidence_update (2026-04-02T16:38)evidence: market_dynamics (2026-04-02T17:18)evidence: market_dynamics_seed (2026-04-02T18:16) 1.00 0.00 2026-04-022026-04-112026-04-28 Market PriceScoreevidencedebate 240 events
    7d Trend
    Falling
    7d Momentum
    ▼ 12.0%
    Volatility
    Low
    0.0148
    Events (7d)
    6
    ⚡ Price Movement Log Recent 15 events
    Event Price Change Source Time
    Recalibrated $0.517 ▼ 1.1% 2026-04-12 18:34
    Recalibrated $0.523 ▼ 0.2% 2026-04-12 10:15
    Recalibrated $0.524 ▼ 1.8% 2026-04-12 05:13
    Recalibrated $0.533 ▼ 0.5% 2026-04-10 15:58
    Recalibrated $0.536 ▲ 0.6% 2026-04-10 15:53
    Recalibrated $0.533 ▼ 8.9% 2026-04-08 18:39
    Recalibrated $0.585 ▲ 3.2% 2026-04-06 04:04
    Recalibrated $0.567 ▼ 1.0% 2026-04-04 16:38
    Recalibrated $0.573 ▲ 1.7% 2026-04-04 16:02
    Recalibrated $0.563 ▼ 0.8% 2026-04-04 01:39
    Recalibrated $0.567 ▼ 24.7% 2026-04-03 23:46
    Recalibrated $0.754 ▲ 5.2% market_dynamics 2026-04-03 01:06
    Recalibrated $0.717 ▲ 19.8% market_dynamics 2026-04-03 01:06
    Recalibrated $0.598 ▲ 3.8% 2026-04-02 21:55
    Recalibrated $0.577 ▼ 0.6% market_recalibrate 2026-04-02 19:14

    Clinical Trials (3) Relevance: 4%

    0
    Active
    0
    Completed
    0
    Total Enrolled
    Clinical trial NCT03367988 Unknown
    Unknown · NCT03367988
    Clinical trial NCT02913664 Unknown
    Unknown · NCT02913664
    Clinical trial NCT01409564 Unknown
    Unknown · NCT01409564

    📚 Cited Papers (48)

    1 figure
    Figures
    Figures
    Figures available at source paper (no open-access XML found).
    deep_link
    Raccoon eyes
    Journal of Paediatrics and Child Health (2023) · PMID:35789012
    1 figure
    Figures
    Figures
    Figures available at source paper (no open-access XML found).
    deep_link
    1 figure
    Figures
    Figures
    Figures available at source paper (no open-access XML found).
    deep_link
    9 figures
    Fig 1
    Fig 1
    CYP46A1 and 24-OHC are up-regulated in PD patients and PD model mice.
    pmc_api
    Fig 2
    Fig 2
    α-Syn pathology and its spread are significantly reduced after CYP46A1 removal in vivo.
    pmc_api
    1 figure
    Figures
    Figures
    Figures available at source paper (no open-access XML found).
    deep_link
    Deep anaesthesia.
    Lancet (London, England) (2020) · PMID:32891204
    1 figure
    Figures
    Figures
    Figures available at source paper (no open-access XML found).
    deep_link
    7 figures
    Figure 1.
    Figure 1.
    Supra-pharmacological Metformin Concentrations Reduce Adenine Nucleotides and Mitochondrial Respiration (A and B) After24 h of planting, primary hepatocytes were treated with diffe...
    pmc_api
    Figure 2.
    Figure 2.
    Determination of Metformin Concentrations in Cellular Compartments of Hepatocytes (A and B) Hepa1–6 cells were treated with different concentrations of metformin as In Figure 1A ,...
    pmc_api
    1 figure
    Figures
    Figures
    Figures available at source paper (no open-access XML found).
    deep_link
    9 figures
    Figure 1
    Figure 1
    A β- induced axonal damage. Following the intracerebral injection of fA β into the hippocampus, small blocks of tissue brain containing the lesion area were postfixed in osmium te...
    pmc_api
    Figure 2
    Figure 2
    A cholesterol-enriched diet was significantly related to a more important loss of the mitochondrial integrity in animals. The graph shows differences among PBS-injected brains from...
    pmc_api
    TREM2, microglia, and Alzheimer's disease.
    Mech Ageing Dev (2021) · PMID:33516818
    1 figure
    Figures
    Figures
    Figures available at source paper (no open-access XML found).
    deep_link
    6 figures
    Figure 1
    Figure 1
    Distribution of raft and non-raft components in Triton isolated neuronal DRMs . Triton lysates of primary cortical cultures were fractionated by sucrose gradient ultracentrifugatio...
    pmc_api
    Figure 2
    Figure 2
    Altered distribution of flotillin-1 in neuronal DRMs isolated with different detergents . A . Equal volumes of primary cortical lysates were incubated with the indicated detergent...
    pmc_api
    7 figures
    Fig. 1
    Fig. 1
    Aberrant ATAD3A oligomerization in AD models.
    pmc_api
    Fig. 2
    Fig. 2
    ATAD3A oligomerization impairs MAM integrity under AD conditions.
    pmc_api

    📅 Citation Freshness Audit

    Freshness score = exp(-age×ln2/5): halves every 5 years. Green >0.6, Amber 0.3–0.6, Red <0.3.

    No citation freshness data yet. Export bibliography — run scripts/audit_citation_freshness.py to populate.

    📓 Linked Notebooks (7)

    📓 Lipid raft composition changes in synaptic neurodegeneration — Analysis Notebook
    CI-generated notebook stub for analysis SDA-2026-04-01-gap-lipid-rafts-2026-04-01. Investigate how lipid raft composition (cholesterol metabolism, sphingolipids) changes in synaptic membranes during n …
    📓 Lipid raft composition — Analysis Notebook
    Comprehensive analysis notebook
    📓 Lipid raft composition changes in synaptic neurodegeneration - Rich Analysis
    Rich notebook with gene expression, pathway enrichment, and statistical analysis
    📓 Lipid raft composition changes in synaptic neurodegeneration - Top 5 Rich Notebook
    Rich notebook with gene expression, pathway enrichment, KG network, score heatmaps, and statistical analysis.
    📓 Lipid raft composition changes in synaptic neurodegeneration — Rich Analysis
    Enhanced notebook with gene expression, pathway enrichment, score heatmaps, and statistical analysis. Investigate how lipid raft composition (cholesterol metabolism, sphingolipids) changes in synaptic …
    📓 Lipid raft composition changes in synaptic neurodegeneration -- Rich Analysis Notebook
    Comprehensive analysis with gene expression plots, pathway enrichment, statistical tests, and debate highlights for: Lipid raft composition changes in synaptic neurodegeneration
    📓 Lipid raft composition changes in synaptic neurodegeneration
    Investigate how lipid raft composition (cholesterol metabolism, sphingolipids) changes in synaptic membranes during neurodegeneration and their mechanistic role in amyloid-beta processing and synapse …
    → Browse all notebooks

    ⚔ Arena Performance

    No arena matches recorded yet. Browse Arenas
    → Browse all arenas & tournaments

    📊 Resource Economics & ROI

    High Efficiency Resource Efficiency Score
    0.86
    62.5th percentile (776 hypotheses)
    Tokens Used
    6,242
    KG Edges Generated
    16
    Citations Produced
    34

    Cost Ratios

    Cost per KG Edge
    35.07 tokens
    Lower is better (baseline: 2000)
    Cost per Citation
    260.08 tokens
    Lower is better (baseline: 1000)
    Cost per Score Point
    9059.51 tokens
    Tokens / composite_score

    Score Impact

    Efficiency Boost to Composite
    +0.086
    10% weight of efficiency score
    Adjusted Composite
    0.794

    How Economics Pricing Works

    Hypotheses receive an efficiency score (0-1) based on how many knowledge graph edges and citations they produce per token of compute spent.

    High-efficiency hypotheses (score >= 0.8) get a price premium in the market, pulling their price toward $0.580.

    Low-efficiency hypotheses (score < 0.6) receive a discount, pulling their price toward $0.420.

    Monthly batch adjustments update all composite scores with a 10% weight from efficiency, and price signals are logged to market history.

    Efficiency Price Signals

    Date Signal Price Score
    2026-04-16T20:00$0.5110.580

    📋 Reviews View all →

    Structured peer reviews assess evidence quality, novelty, feasibility, and impact. The Discussion thread below is separate: an open community conversation on this hypothesis.

    💬 Discussion

    No DepMap CRISPR Chronos data found for ABCA1/LDLR/SREBF2.

    Run python3 scripts/backfill_hypothesis_depmap.py to populate.

    No curated ClinVar variants loaded for this hypothesis.

    Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

    🔍 Search ClinVar for ABCA1/LDLR/SREBF2 →
    Loading history…

    ⚖️ Governance History

    No governance decisions recorded for this hypothesis.

    Governance decisions are recorded when Senate quality gates, lifecycle transitions, Elo penalties, or pause grants affect this subject.

    Browse all governance decisions →

    Wiki Pages

    ANG — AngiogeningeneANG ProteinproteinABCA1 - ATP-Binding Cassette Transporter A1geneSREBF2 — Sterol Regulatory Element Binding TranscrgeneLDLR GenegeneMetabolomic Biomarkers in NeurodegenerationbiomarkerNeuroimaging Biomarkers for NeurodegenerationbiomarkerSynaptic Biomarkers in NeurodegenerationbiomarkerExosomal Biomarkers in NeurodegenerationbiomarkerDNA Methylation Biomarkers in NeurodegenerationbiomarkerLiquid Biopsy in NeurodegenerationbiomarkerIL-6 (Interleukin-6) in NeurodegenerationbiomarkerMDS 2026 — Fluid Biomarker Advances in NeurodegeneeventCell-Free DNA Biomarkers in NeurodegenerationbiomarkerExosomal miR-155 in Neurodegenerationbiomarker

    KG Entities (48)

    ABCA1ABCA1/LDLR/SREBF2ADAM10AKTAPPAcid sphingomyelinase / ceramide signaliBACE1BACE1_clusteringBAXBeta-secretase / amyloidogenic pathwayCYP46A1Cholesterol 24-hydroxylase / brain choleCholesterol efflux / lipid transportFLOT1JNKLDLRLipid raft membrane organizationNLRP3SGMS1SGMS1/SGMS2

    Linked Experiments (1)

    Metal Ion Homeostasis Dysregulation in Alzheimer's Diseasevalidation | tests | 0.40

    Related Hypotheses

    Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming in Neurodegeneration
    Score: 0.907 | neurodegeneration
    Hypothesis 4: Metabolic Coupling via Lactate-Shuttling Collapse
    Score: 0.895 | neurodegeneration
    SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senescence
    Score: 0.893 | neurodegeneration
    TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegeneration
    Score: 0.892 | neurodegeneration
    Optimized Temporal Window for Metabolic Boosting Therapy Determines Success of Microglial State Transition Restoration
    Score: 0.887 | neurodegeneration

    Estimated Development

    Estimated Cost
    $0
    Timeline
    5.0 years

    🧪 Falsifiable Predictions (5)

    5 total 0 confirmed 0 falsified
    If hypothesis is true, intervention concentrate in pathological rafts
    pending conf: 0.85
    Expected outcome: concentrate in pathological rafts
    Falsified by: Intervention fails to concentrate in pathological rafts
    If hypothesis is true, intervention achieve differential localization
    pending conf: 0.85
    Expected outcome: achieve differential localization
    Falsified by: Intervention fails to achieve differential localization
    If hypothesis is true, intervention selectively inhibit ABCA1 while sparing or enhancing ABCA7
    pending conf: 0.85
    Expected outcome: selectively inhibit ABCA1 while sparing or enhancing ABCA7
    Falsified by: Intervention fails to selectively inhibit ABCA1 while sparing or enhancing ABCA7
    If hypothesis is true, intervention be beneficial (enhanced synaptic cholesterol production) or detrimental (restoration of pathological raft cholesterol)
    pending conf: 0.85
    Expected outcome: be beneficial (enhanced synaptic cholesterol production) or detrimental (restoration of pathological raft cholesterol)
    Falsified by: Intervention fails to be beneficial (enhanced synaptic cholesterol production) or detrimental (restoration of pathological raft cholesterol)
    If hypothesis is true, intervention translate to measurable Aβ reduction
    pending conf: 0.85
    Expected outcome: translate to measurable Aβ reduction
    Falsified by: Intervention fails to translate to measurable Aβ reduction

    Knowledge Subgraph (169 edges)

    activates (2)

    BACE1_clusteringamyloid_beta_productionsphingomyelin_synthesismembrane_fluidity

    associated with (13)

    cholesterol_effluxlipid_raft_compositionFLOT1lipid_raft_scaffoldingABCA1neurodegenerationSREBF2neurodegenerationCYP46A1neurodegeneration
    ▸ Show 8 more

    causes (1)

    ceramide_biosynthesislipid_raft_dysfunction

    co associated with (14)

    ABCA1/LDLR/SREBF2FLOT1ABCA1/LDLR/SREBF2SGMS1/SGMS2ABCA1/LDLR/SREBF2BACE1BACE1FLOT1BACE1SGMS1/SGMS2
    ▸ Show 9 more

    co discussed (102)

    BACE1NLRP3AKTBACE1BAXJNKADAM10APPADAM10BACE1
    ▸ Show 97 more
    BACE1TAUFLOT1SREBF2FLOT1CYP46A1FLOT1SGMS2FLOT1ABCA1FLOT1BACE1FLOT1ST3GAL2FLOT1ST8SIA1FLOT1LDLRFLOT1SMPD1FLOT1SGMS1SREBF2CYP46A1SREBF2SGMS2SREBF2ABCA1SREBF2BACE1SREBF2ST3GAL2SREBF2ST8SIA1SREBF2LDLRSREBF2SMPD1SREBF2SGMS1CYP46A1SGMS2CYP46A1ABCA1CYP46A1BACE1CYP46A1ST3GAL2CYP46A1ST8SIA1CYP46A1LDLRCYP46A1SMPD1CYP46A1SGMS1SGMS2ABCA1SGMS2BACE1SGMS2ST3GAL2SGMS2ST8SIA1SGMS2LDLRSGMS2SMPD1SGMS2SGMS1ABCA1BACE1ABCA1ST3GAL2ABCA1ST8SIA1ABCA1SMPD1ABCA1SGMS1BACE1ST3GAL2BACE1ST8SIA1BACE1LDLRBACE1SMPD1BACE1SGMS1ST3GAL2ST8SIA1ST3GAL2LDLRST3GAL2SMPD1ST3GAL2SGMS1ST8SIA1LDLRST8SIA1SMPD1ST8SIA1SGMS1LDLRSMPD1LDLRSGMS1SMPD1SGMS1ST8SIA1BACE1ST8SIA1CYP46A1ST8SIA1ST3GAL2ST8SIA1FLOT1ST8SIA1ABCA1ST8SIA1SGMS2ST8SIA1SREBF2LDLRBACE1LDLRCYP46A1LDLRST3GAL2LDLRFLOT1LDLRABCA1LDLRSGMS2LDLRSREBF2BACE1FLOT1BACE1ABCA1BACE1SGMS2BACE1SREBF2CYP46A1FLOT1CYP46A1SREBF2ST3GAL2FLOT1ST3GAL2ABCA1ST3GAL2SGMS2ST3GAL2SREBF2SGMS1FLOT1SGMS1ABCA1SGMS1SMPD1SGMS1SREBF2ABCA1SGMS2ABCA1SREBF2SGMS2SREBF2SMPD1SREBF2SMPD1LDLRSMPD1ST3GAL2SMPD1ST8SIA1SMPD1ABCA1SMPD1SGMS2SMPD1CYP46A1LDLRST8SIA1ST3GAL2CYP46A1ABCA1CYP46A1SGMS2CYP46A1

    interacts with (10)

    ABCA1LDLRABCA1SREBF2LDLRABCA1LDLRSREBF2SREBF2ABCA1
    ▸ Show 5 more

    involved in (6)

    ABCA1/LDLR/SREBF2cholesterol_efflux___lipid_transportCYP46A1cholesterol_24_hydroxylase___brain_cholesterol_turnoverST3GAL2/ST8SIA1sphingolipid___ceramide_signalingSGMS1/SGMS2sphingolipid___ceramide_signalingFLOT1lipid_raft_membrane_organization
    ▸ Show 1 more

    modifies (3)

    SMPD1ceramide_biosynthesisSGMS1sphingomyelin_synthesisST3GAL2ganglioside_biosynthesis

    participates in (11)

    SMPD1Acid sphingomyelinase / ceramide signalingABCA1Cholesterol efflux / lipid transportLDLRCholesterol efflux / lipid transportSREBF2Cholesterol efflux / lipid transportCYP46A1Cholesterol 24-hydroxylase / brain cholesterol turnover
    ▸ Show 6 more

    regulates (4)

    CYP46A1cholesterol_metabolismcholesterol_metabolismBACE1_clusteringABCA1cholesterol_effluxganglioside_biosynthesissynaptic_membrane_organization

    targets (3)

    h-9d29bfe5ABCA1/LDLR/SREBF2h-fdb07848SGMS1/SGMS2h-12599989ST3GAL2/ST8SIA1

    Mechanism Pathway for ABCA1/LDLR/SREBF2

    Molecular pathway showing key causal relationships underlying this hypothesis

    graph TD
        h_9d29bfe5["h-9d29bfe5"] -->|targets| ABCA1_LDLR_SREBF2["ABCA1/LDLR/SREBF2"]
        ABCA1_LDLR_SREBF2_1["ABCA1/LDLR/SREBF2"] -->|associated with| neurodegeneration["neurodegeneration"]
        ABCA1_LDLR_SREBF2_2["ABCA1/LDLR/SREBF2"] -->|co associated with| FLOT1["FLOT1"]
        ABCA1_LDLR_SREBF2_3["ABCA1/LDLR/SREBF2"] -->|co associated with| SGMS1_SGMS2["SGMS1/SGMS2"]
        ABCA1_LDLR_SREBF2_4["ABCA1/LDLR/SREBF2"] -->|co associated with| BACE1["BACE1"]
        ABCA1_LDLR_SREBF2_5["ABCA1/LDLR/SREBF2"] -->|co associated with| CYP46A1["CYP46A1"]
        ABCA1_LDLR_SREBF2_6["ABCA1/LDLR/SREBF2"] -->|co associated with| ST3GAL2_ST8SIA1["ST3GAL2/ST8SIA1"]
        ABCA1_LDLR_SREBF2_7["ABCA1/LDLR/SREBF2"] -->|involved in| cholesterol_efflux___lipi["cholesterol_efflux___lipid_transport"]
        style h_9d29bfe5 fill:#4fc3f7,stroke:#333,color:#000
        style ABCA1_LDLR_SREBF2 fill:#ce93d8,stroke:#333,color:#000
        style ABCA1_LDLR_SREBF2_1 fill:#ce93d8,stroke:#333,color:#000
        style neurodegeneration fill:#ef5350,stroke:#333,color:#000
        style ABCA1_LDLR_SREBF2_2 fill:#ce93d8,stroke:#333,color:#000
        style FLOT1 fill:#ce93d8,stroke:#333,color:#000
        style ABCA1_LDLR_SREBF2_3 fill:#ce93d8,stroke:#333,color:#000
        style SGMS1_SGMS2 fill:#ce93d8,stroke:#333,color:#000
        style ABCA1_LDLR_SREBF2_4 fill:#ce93d8,stroke:#333,color:#000
        style BACE1 fill:#ce93d8,stroke:#333,color:#000
        style ABCA1_LDLR_SREBF2_5 fill:#ce93d8,stroke:#333,color:#000
        style CYP46A1 fill:#ce93d8,stroke:#333,color:#000
        style ABCA1_LDLR_SREBF2_6 fill:#ce93d8,stroke:#333,color:#000
        style ST3GAL2_ST8SIA1 fill:#ce93d8,stroke:#333,color:#000
        style ABCA1_LDLR_SREBF2_7 fill:#ce93d8,stroke:#333,color:#000
        style cholesterol_efflux___lipi fill:#81c784,stroke:#333,color:#000

    3D Protein Structure

    🧬 ABCA1 — PDB 7TBJ Click to expand 3D viewer

    Experimental structure from RCSB PDB | Powered by Mol* | Rotate: click+drag | Zoom: scroll | Reset: right-click

    Source Analysis

    Lipid raft composition changes in synaptic neurodegeneration

    neurodegeneration | 2026-04-01 | completed

    Community Feedback

    0 0 upvotes · 0 downvotes
    💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

    No comments yet. Be the first to comment!

    View all feedback (JSON)

    Same Analysis (5)

    Senescent Cell ASM-Complement Cascade Intervention
    Score: 0.85 · SMPD1
    Neutral Sphingomyelinase-2 Inhibition for Synaptic Protection in Neuro
    Score: 0.84 · SMPD3
    Selective Acid Sphingomyelinase Modulation Therapy
    Score: 0.75 · SMPD1
    Selective Neutral Sphingomyelinase-2 Inhibition Therapy
    Score: 0.73 · SMPD3
    CYP46A1 Overexpression Gene Therapy
    Score: 0.73 · CYP46A1
    → View all analysis hypotheses
    Public annotations (0)Annotate on Hypothes.is →
    No public annotations yet.